$MRNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Moderna, Inc.. Get notifications about new insider transactions in Moderna, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 479,822 | |
Jun 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 200.86 | 5,000 | 1,004,300 | 0 | 5 K to 0 (-100.00 %) |
Jun 23 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 25.93 | 5,000 | 129,650 | 141,120 | |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 183.90 | 5,000 | 919,500 | 0 | 5 K to 0 (-100.00 %) |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 25.93 | 5,000 | 129,650 | 5,000 | 0 to 5 K |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 25.93 | 5,000 | 129,650 | 141,120 | |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 183.90 | 5,000 | 919,500 | 0 | 5 K to 0 (-100.00 %) |
Jun 03 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 25.93 | 5,000 | 129,650 | 5,000 | 0 to 5 K |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 168.49 | 500 | 84,245 | 11,062 | 11.6 K to 11.1 K (-4.32 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 167.39 | 887 | 148,475 | 11,562 | 12.4 K to 11.6 K (-7.13 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 166.37 | 1,159 | 192,823 | 12,449 | 13.6 K to 12.4 K (-8.52 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 165.46 | 600 | 99,276 | 13,608 | 14.2 K to 13.6 K (-4.22 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 164.15 | 1,100 | 180,565 | 14,208 | 15.3 K to 14.2 K (-7.19 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 163.09 | 4,150 | 676,824 | 15,308 | 19.5 K to 15.3 K (-21.33 %) |
May 25 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 162.30 | 2,650 | 430,095 | 19,458 | 22.1 K to 19.5 K (-11.99 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 162.08 | 100 | 16,208 | 22,108 | 22.2 K to 22.1 K (-0.45 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 161.50 | 1,191 | 192,347 | 22,208 | 23.4 K to 22.2 K (-5.09 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 160.18 | 400 | 64,072 | 23,399 | 23.8 K to 23.4 K (-1.68 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 158.60 | 1,691 | 268,193 | 23,799 | 25.5 K to 23.8 K (-6.63 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 157.53 | 1,785 | 281,191 | 25,490 | 27.3 K to 25.5 K (-6.54 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 156.54 | 1,884 | 294,921 | 27,275 | 29.2 K to 27.3 K (-6.46 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 155.72 | 1,079 | 168,022 | 29,159 | 30.2 K to 29.2 K (-3.57 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 154.76 | 592 | 91,618 | 30,238 | 30.8 K to 30.2 K (-1.92 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 153.44 | 300 | 46,032 | 30,830 | 31.1 K to 30.8 K (-0.96 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 152.34 | 1,524 | 232,166 | 31,130 | 32.7 K to 31.1 K (-4.67 %) |
May 18 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 150.97 | 500 | 75,485 | 32,654 | 33.2 K to 32.7 K (-1.51 %) |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 487,431 | |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 316,972 | |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 321,972 | |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 152.60 | 15,000 | 2,289,000 | 1,609,597 | 1.6 M to 1.6 M (-0.92 %) |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,624,597 | 1.6 M to 1.6 M (+0.62 %) |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 154.11 | 5,000 | 770,550 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
May 14 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
May 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 25.93 | 5,000 | 129,650 | 156,120 | |
May 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 154.11 | 5,000 | 770,550 | 0 | 5 K to 0 (-100.00 %) |
May 13 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 25.93 | 5,000 | 129,650 | 5,000 | 0 to 5 K |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 3,670 | 44,811 | 137,612 | |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 163.12 | 200 | 32,624 | 0 | 200 to 0 (-100.00 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 161.64 | 100 | 16,164 | 200 | 300 to 200 (-33.33 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 159.63 | 200 | 31,926 | 300 | 500 to 300 (-40.00 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 158.88 | 1,585 | 251,825 | 500 | 2.1 K to 500 (-76.02 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 157.48 | 985 | 155,118 | 2,085 | 3.1 K to 2.1 K (-32.08 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 156.60 | 600 | 93,960 | 3,070 | 3.7 K to 3.1 K (-16.35 %) |
May 11 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 3,670 | 44,811 | 3,670 | 0 to 3.7 K |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 168.48 | 533 | 89,800 | 33,154 | 33.7 K to 33.2 K (-1.58 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 166.83 | 600 | 100,098 | 33,687 | 34.3 K to 33.7 K (-1.75 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 165.76 | 781 | 129,459 | 34,287 | 35.1 K to 34.3 K (-2.23 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 164.64 | 788 | 129,736 | 35,068 | 35.9 K to 35.1 K (-2.20 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 163.54 | 4,149 | 678,527 | 35,856 | 40 K to 35.9 K (-10.37 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 162.81 | 3,595 | 585,302 | 40,005 | 43.6 K to 40 K (-8.25 %) |
May 11 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 161.18 | 600 | 96,708 | 43,600 | 44.2 K to 43.6 K (-1.36 %) |
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 93,476 | |
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 147.82 | 6,600 | 975,612 | 901 | 7.5 K to 901 (-87.99 %) |
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 100,076 | |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 185.25 | 6,600 | 1,222,650 | 901 | 7.5 K to 901 (-87.99 %) |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
May 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 544,822 | |
May 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 178.34 | 5,000 | 891,700 | 0 | 5 K to 0 (-100.00 %) |
May 06 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 141,282 | |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 188.00 | 916 | 172,208 | 0 | 916 to 0 (-100.00 %) |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 187.10 | 1,924 | 359,980 | 916 | 2.8 K to 916 (-67.75 %) |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 186.04 | 1,089 | 202,598 | 2,840 | 3.9 K to 2.8 K (-27.72 %) |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 184.77 | 800 | 147,816 | 3,929 | 4.7 K to 3.9 K (-16.92 %) |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 183.42 | 271 | 49,707 | 4,729 | 5 K to 4.7 K (-5.42 %) |
May 04 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
May 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 549,822 | |
May 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 183.66 | 5,000 | 918,300 | 0 | 5 K to 0 (-100.00 %) |
May 04 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 497,431 | |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 507,431 | |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 183.66 | 20,000 | 3,673,200 | 1,609,597 | 1.6 M to 1.6 M (-1.23 %) |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,629,597 | 1.6 M to 1.6 M (+0.62 %) |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,619,597 | 1.6 M to 1.6 M (+0.62 %) |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 497,431 | |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 507,431 | |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 183.66 | 20,000 | 3,673,200 | 1,609,597 | 1.6 M to 1.6 M (-1.23 %) |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,629,597 | 1.6 M to 1.6 M (+0.62 %) |
May 04 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,619,597 | 1.6 M to 1.6 M (+0.62 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 182.49 | 10,000 | 1,824,900 | 7,434,880 | 7.4 M to 7.4 M (-0.13 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,334,868 | 6.3 M to 6.3 M (-0.03 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 182.32 | 9,000 | 1,640,880 | 6,336,868 | 6.3 M to 6.3 M (-0.14 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 106,676 | |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 182.49 | 6,600 | 1,204,434 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | Tallett Elizabeth E | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
Apr 30 2021 | MRNA | Moderna, Inc. | Tallett Elizabeth E | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
Apr 30 2021 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
Apr 30 2021 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
Apr 30 2021 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 113,276 | |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 178.29 | 6,600 | 1,176,714 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 559,822 | |
Apr 27 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 171.77 | 5,000 | 858,850 | 0 | 5 K to 0 (-100.00 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 146,282 | |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 179.37 | 100 | 17,937 | 0 | 100 to 0 (-100.00 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 178.51 | 1,829 | 326,495 | 100 | 1.9 K to 100 (-94.82 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 177.41 | 900 | 159,669 | 1,929 | 2.8 K to 1.9 K (-31.81 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 175.97 | 551 | 96,959 | 2,829 | 3.4 K to 2.8 K (-16.30 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 175.03 | 400 | 70,012 | 3,380 | 3.8 K to 3.4 K (-10.58 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 173.03 | 200 | 34,606 | 3,780 | 4 K to 3.8 K (-5.03 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 171.65 | 1 | 172 | 3,980 | 4 K to 4 K (-0.03 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 171.05 | 439 | 75,091 | 3,981 | 4.4 K to 4 K (-9.93 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 169.87 | 580 | 98,525 | 4,420 | 5 K to 4.4 K (-11.60 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 326,972 | |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 0.99 | 10,000 | 9,900 | 517,431 | |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Option Exercise | M | 10.90 | 5,000 | 54,500 | 331,972 | |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 171.77 | 5,000 | 858,850 | 1,609,597 | 1.6 M to 1.6 M (-0.31 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 175.34 | 100 | 17,534 | 1,609,597 | 1.6 M to 1.6 M (-0.01 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 174.46 | 1,400 | 244,244 | 1,609,697 | 1.6 M to 1.6 M (-0.09 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 173.81 | 4,639 | 806,305 | 1,611,097 | 1.6 M to 1.6 M (-0.29 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 172.81 | 2,200 | 380,182 | 1,615,736 | 1.6 M to 1.6 M (-0.14 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 171.77 | 1,000 | 171,770 | 1,617,936 | 1.6 M to 1.6 M (-0.06 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 170.18 | 5,100 | 867,918 | 1,618,936 | 1.6 M to 1.6 M (-0.31 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 169.18 | 561 | 94,910 | 1,624,036 | 1.6 M to 1.6 M (-0.03 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 0.99 | 10,000 | 9,900 | 1,624,597 | 1.6 M to 1.6 M (+0.62 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Hoge Stephen | President | Buy | M | 10.90 | 5,000 | 54,500 | 1,614,597 | 1.6 M to 1.6 M (+0.31 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 175.32 | 100 | 17,532 | 55,246 | 55.3 K to 55.2 K (-0.18 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 174.13 | 4,985 | 868,038 | 55,346 | 60.3 K to 55.3 K (-8.26 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 173.17 | 3,500 | 606,095 | 60,331 | 63.8 K to 60.3 K (-5.48 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 172.22 | 1,300 | 223,886 | 63,831 | 65.1 K to 63.8 K (-2.00 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 171.13 | 661 | 113,117 | 65,131 | 65.8 K to 65.1 K (-1.00 %) |
Apr 27 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 169.17 | 500 | 84,585 | 65,792 | 66.3 K to 65.8 K (-0.75 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 119,876 | |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 168.26 | 6,600 | 1,110,516 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 168.26 | 10,000 | 1,682,600 | 7,444,880 | 7.5 M to 7.4 M (-0.13 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,345,868 | 6.3 M to 6.3 M (-0.03 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 158.60 | 9,000 | 1,427,400 | 6,347,868 | 6.4 M to 6.3 M (-0.14 %) |
Apr 22 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 564,822 | |
Apr 22 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 158.60 | 5,000 | 793,000 | 0 | 5 K to 0 (-100.00 %) |
Apr 22 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 126,476 | |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 160.32 | 6,600 | 1,058,112 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 569,822 | |
Apr 20 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 166.17 | 5,000 | 830,850 | 0 | 5 K to 0 (-100.00 %) |
Apr 20 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 151,282 | |
Apr 20 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 167.56 | 100 | 16,756 | 0 | 100 to 0 (-100.00 %) |